Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 1 result.
    • Article de périodique
    Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
    Pienta, Kenneth J Machiels, Jean-Pascal[UCL] Schrijvers, Dirk Alekseev, Boris Shkolnik, Mikhail Crabb, Simon J Li, Susan Seetharam, Shobha Puchalski, Thomas A Takimoto, Chris Elsayed, Yusri Dawkins, Fitzroy de Bono, Johann S (2012) Investigational New Drugs : the journal of new anti-cancer agents — Vol. 31, no. 3, p. 760-768 (2012)